# 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

> **NCT01524016** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Oncogenic Osteomalacia
- Mesenchymal Tumor

## Interventions

- **DRUG:** 68Ga-DOTATATE

## Key facts

- **NCT ID:** NCT01524016
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524016, "68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01524016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*